SRF (SRF) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Q1 FY2025 was challenging, with gross operating revenue at ₹3,464.1 crore, EBITDA down 11.7%, and PAT down 29.8% year-over-year, mainly due to headwinds in the chemicals business, though packaging films and technical textiles showed growth.
The Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, with no material misstatements identified by auditors.
An interim dividend of ₹3.60 per share (36%) was declared.
The company continues to focus on R&D, innovation, and expanding high-value product offerings.
Financial highlights
Consolidated gross operating revenue was ₹3,464.1 crore (up 3.8% year-over-year), with EBITDA at ₹645.9 crore (down 11.7%) and PAT at ₹252.2 crore (down 29.8%).
Chemical business revenue declined 10.8% YoY to ₹1,482 crore, while packaging films grew 22.1% YoY to ₹1,336.3 crore, and technical textiles increased 13.1% YoY to ₹525.3 crore.
Basic and diluted EPS was ₹8.51, compared to ₹12.12 in Q1 FY24.
Standalone revenue and net profit declined both sequentially and year-over-year.
Outlook and guidance
Management maintains 20% growth guidance for specialty chemicals, expecting H2 to compensate for H1 shortfalls.
CapEx for FY2025 projected at ₹1,300–1,900 crore, with a six-year plan of ₹12,000–15,000 crore on track.
New HF plant commissioning in Q2 FY25 to provide cost advantages; aluminium foil facility to contribute positively.
Commercial paper program remains highly rated, with all due commercial papers repaid during the quarter.
Latest events from SRF
- Profit and revenue surged, led by Chemicals, with margin pressure in Textiles and interim dividend.SRF
Q3 25/2620 Jan 2026 - Q2 FY25 revenue up 8% YoY, but profit fell 33% as margins contracted and chemicals lagged.SRF
Q2 24/2518 Jan 2026 - Q3 FY25 revenue and profit grew strongly, led by Chemicals and Packaging Films; dividend declared.SRF
Q3 24/259 Jan 2026 - Q2 FY26 saw strong revenue, profit, and margin growth, driven by Chemicals and higher CapEx.SRF
Q2 25/2622 Dec 2025 - Strong revenue and profit growth, improved margins, and interim dividend declared.SRF
Q1 25/2620 Nov 2025 - FY25 revenue up 12% to ₹14,693 crore, net profit down, with strong Q4 and higher FY26 CapEx ahead.SRF
Q4 24/2520 Nov 2025